These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 32195888)

  • 1. Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types.
    Tavoosi A; Yu B; Aghel N; Karur GR; Pakkal M; Wald R; Wintersperger BJ; Delgado DH; Hanneman K
    J Thorac Imaging; 2020 Sep; 35(5):334-339. PubMed ID: 32195888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the inversion scout sequence (TI scout) in diagnosing myocardial amyloid infiltration.
    Pandey T; Jambhekar K; Shaikh R; Lensing S; Viswamitra S
    Int J Cardiovasc Imaging; 2013 Jan; 29(1):103-12. PubMed ID: 22527255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial nulling pattern in cardiac amyloidosis on time of inversion scout magnetic resonance imaging sequence - A new observation of temporal variability.
    Mahalingam H; Chacko BR; Irodi A; Joseph E; Vimala LR; Thomson VS
    Indian J Radiol Imaging; 2018; 28(4):427-432. PubMed ID: 30662203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic Resonance Imaging in Cardiac Amyloidosis: Unraveling the Stealth Entity.
    Shah O; Choh N; Shera T; Shera F; Gojwari T; Shaheen F; Robbani I
    Int J Angiol; 2022 Mar; 31(1):40-47. PubMed ID: 35221851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REPAIRit: Improving Myocardial Nulling and Ghosting Artifacts of 3D Navigator-Gated Late Gadolinium Enhancement Imaging During Arrhythmia.
    Hu C; Huber S; Latif SR; Santacana-Laffitte G; Mojibian HR; Baldassarre LA; Peters DC
    J Magn Reson Imaging; 2019 Mar; 49(3):688-699. PubMed ID: 30252987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Amyloid Quantification with Look-Locker Magnetic Resonance Sequence in Cardiac Amyloidosis. Diagnostic Accuracy in Clinical Practice and Histological Validation.
    Pozo E; Castellano JM; Kanwar A; Deochand R; Castillo-Martin M; Pazos-López P; González-Lengua C; Osman K; Cham M; Cordon-Cardo C; Narula J; Fuster V; Sanz J
    J Card Fail; 2018 Feb; 24(2):78-86. PubMed ID: 28801077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of quantitative imaging parameters using cardiovascular magnetic resonance between cardiac amyloidosis and hypertrophic cardiomyopathy: inversion time scout versus T1 mapping.
    Nam BD; Kim SM; Jung HN; Kim Y; Choe YH
    Int J Cardiovasc Imaging; 2018 Nov; 34(11):1769-1777. PubMed ID: 29846837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly increased volume of distribution of gadolinium in cardiac amyloidosis demonstrated by T1 mapping.
    Brooks J; Kramer CM; Salerno M
    J Magn Reson Imaging; 2013 Dec; 38(6):1591-5. PubMed ID: 23450747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-invasive diagnosis of transthyretin cardiac amyloidosis utilizing typical late gadolinium enhancement pattern on cardiac magnetic resonance and light chains.
    Slivnick JA; Alvi N; Singulane CC; Scheetz S; Goyal A; Patel H; Sarswat N; Addetia K; Fernandes F; Vieira MLC; Cafezeiro CRF; Carvalhal SF; Simonetti OP; Singh J; Lang RM; Zareba KM; Patel AR
    Eur Heart J Cardiovasc Imaging; 2023 May; 24(6):829-837. PubMed ID: 36624559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Nulling of Myocardium and Blood Pool.
    Tailor TD; Mammarappallil JG; Christensen JD
    J Thorac Imaging; 2017 Jan; 32(1):W1-W2. PubMed ID: 27879492
    [No Abstract]   [Full Text] [Related]  

  • 11. Native T1 mapping in transthyretin amyloidosis.
    Fontana M; Banypersad SM; Treibel TA; Maestrini V; Sado DM; White SK; Pica S; Castelletti S; Piechnik SK; Robson MD; Gilbertson JA; Rowczenio D; Hutt DF; Lachmann HJ; Wechalekar AD; Whelan CJ; Gillmore JD; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2014 Feb; 7(2):157-65. PubMed ID: 24412190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular volume with bolus-only technique in amyloidosis patients: Diagnostic accuracy, correlation with other clinical cardiac measures, and ability to track changes in amyloid load over time.
    Zumbo G; Barton SV; Thompson D; Sun M; Abdel-Gadir A; Treibel TA; Knight D; Martinez-Naharro A; Thirusha L; Gillmore JD; Moon JC; Hawkins PN; Fontana M
    J Magn Reson Imaging; 2018 Jun; 47(6):1677-1684. PubMed ID: 29159946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative inversion time prescription for myocardial late gadolinium enhancement using T1-mapping-based synthetic inversion recovery imaging: reducing subjectivity in the estimation of inversion time.
    Gassenmaier S; van der Geest RJ; Schoepf UJ; Suranyi P; Rehwald WG; De Cecco CN; Mastrodicasa D; Albrecht MH; De Santis D; Lesslie VW; Ruzsics B; Varga-Szemes A
    Int J Cardiovasc Imaging; 2018 Jun; 34(6):921-929. PubMed ID: 29305739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
    Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
    Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
    Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
    JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
    Kristen AV; aus dem Siepen F; Scherer K; Kammerer R; Andre F; Buss SJ; Bauer R; Lehrke S; Voss A; Giannitsis E; Katus HA; Steen H
    Amyloid; 2015; 22(2):132-41. PubMed ID: 26053103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D myocardial deformation analysis from cine MRI as a marker of amyloid protein burden in cardiac amyloidosis: validation versus T1 mapping.
    Avitzur N; Satriano A; Afzal M; Narous M; Mikami Y; Hansen R; Dobko G; Flewitt J; Lydell CP; Howarth AG; Chow K; Fine NM; White JA
    Int J Cardiovasc Imaging; 2018 Dec; 34(12):1937-1946. PubMed ID: 30014362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Myocardial Strain in Patients With Amyloidosis Using Cardiac Magnetic Resonance Feature Tracking.
    Pandey T; Alapati S; Wadhwa V; Edupuganti MM; Gurram P; Lensing S; Jambhekar K
    Curr Probl Diagn Radiol; 2017; 46(4):288-294. PubMed ID: 28063633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.
    Rapezzi C; Merlini G; Quarta CC; Riva L; Longhi S; Leone O; Salvi F; Ciliberti P; Pastorelli F; Biagini E; Coccolo F; Cooke RM; Bacchi-Reggiani L; Sangiorgi D; Ferlini A; Cavo M; Zamagni E; Fonte ML; Palladini G; Salinaro F; Musca F; Obici L; Branzi A; Perlini S
    Circulation; 2009 Sep; 120(13):1203-12. PubMed ID: 19752327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography.
    Dorbala S; Vangala D; Semer J; Strader C; Bruyere JR; Di Carli MF; Moore SC; Falk RH
    Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1652-62. PubMed ID: 24841414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.